Lilly Declares Second-Quarter 2022 Dividend

Rhea-AI Summary

Eli Lilly and Company (NYSE: LLY) has declared a $0.98 dividend per share for the second quarter of 2022. This dividend is payable on June 10, 2022, to shareholders of record by May 16, 2022. The company focuses on innovative treatments for significant health challenges impacting millions globally. Lilly’s commitment includes enhancing accessibility and affordability of its medicines, and it has been pioneering advancements for nearly 150 years.

Positive

• Dividend of $0.98 per share boosts shareholder income.
• Commitment to accessibility and affordability supports long-term growth.

Negative

• None.

INDIANAPOLIS, May 2, 2022 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2022 of $0.98 per share on outstanding common stock.

The dividend is payable on June 10, 2022 to shareholders of record at the close of business on May 16, 2022.

About Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom. F-LLY

Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about expected dividend payments and reflects Lilly's current beliefs and expectations. However, there are significant risks and uncertainties in pharmaceutical research and development, as well as in business development activities and capital allocation strategies related to the company's business and actual results may differ materially due to various factors. For further discussion of risks and uncertainties relevant to Lilly's business that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.

Refer to:	Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media)
	Kevin Hern; hern_kevin_r@lilly.com; 317-277-1838 (Investors)

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-declares-second-quarter-2022-dividend-301537579.html

SOURCE Eli Lilly and Company

FAQ

What is the dividend amount declared by LLY for Q2 2022?

Eli Lilly declared a dividend of $0.98 per share for the second quarter of 2022.

When will the dividend for LLY be paid?

The dividend will be paid on June 10, 2022.

What is the record date for the LLY dividend payment?

The record date for the dividend payment is May 16, 2022.

How does LLY ensure the accessibility of its medicines?

Lilly aims to enhance the accessibility and affordability of its medicines as part of its commitment to healthcare.